Analysis of children’s drug use in Inner Mongolia based on big data of drug monitoring
- VernacularTitle:基于药品监测大数据的内蒙古自治区儿童药品使用情况分析
- Author:
Yufang ZHAO
1
,
2
;
Wenpu LEI
1
,
2
;
Zhien LIU
1
,
2
;
Shengnan YANG
1
,
2
;
Yanan ZHANG
1
,
2
;
Ke ZHAO
1
,
2
;
Hao GUO
1
Author Information
1. Dept. of Pharmacy，Inner Mongolia Autonomous Region People’s Hospital，Hohhot 010017，China
2. Center for Essential Medicine Monitoring and Clinical Comprehensive Evaluation of Inner Mongolia Autonomous Region，Hohhot 010017，China
- Publication Type:Journal Article
- Keywords:
children’s drug;
Inner Mongolia Autonomous
- From:
China Pharmacy
2024;35(23):2929-2935
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To analyze the use of children’s drugs in public medical institutions in the Inner Mongolia Autonomous Region， and provide some reference for the rational use of children’s drugs and the improvement of children’s drug list in the whole region. METHODS The generic names， specifications， and dosage forms of children’s drugs were collected from all levels of public medical institutions in the Inner Mongolia Autonomous Region in 2023. The method of defined daily dose （DDD） and ranking ratio （B/A） were used to explore the frequency of drug use， daily average cost and cost-effectiveness of children’s drugs in this region， and the dosage forms， category， and drug use convergence of children’s drugs in medical institutions in the whole region. RESULTS In 2023， 1 751 public medical and health institutions in Inner Mongolia Autonomous Region were equipped with 267 kinds of children’s drugs， including 12 drug categories. The main dosage forms were granules， oral solutions， and syrups. The drugs that were frequently used in medical institutions at all levels were mainly antipyretic， analgesic， anti-inflammatory drugs （mostly Chinese patent medicines）， and respiratory drugs. The daily average cost of children’s drugs with the highest DDDs in tertiary， secondary， and primary public medical institutions was low， and the B/A value of most drugs with higher DDDs was around 1. However， the B/A value of some drugs was high， which may lead to overuse. The drug use convergence between primary public medical institutions and secondary/tertiary public medical institutions was less than 50%. CONCLUSIONS The types of drugs involved in children’s drugs in Inner Mongolia Autonomous Region are comprehensive and the social and economic benefits are in good synchronization， but the dosage form is single and there are few special rules and dosage forms for children. The proportions of Chinese patent medicines in primary and secondary public medical institutions are high， and the risk of drug use should be paid attention. The cohesion between children’s drugs in primary public medical institutions and higher public medical institutions is slightly poor.
